Introducing: If 400m+ people live with COPD, why aren’t we talking about it?
Welcome to Behind the Science with GSK, hosted by Dr. Kat Arney. In this new podcast, we unpack how today’s discoveries are shaping tomorrow’s health. Each episode brings you closer to the people and ideas having an impact on patients, communities and health systems around the world. Behind the Science is developed and funded by GSK. In this episode Kaivan Khavandi and Dave Singh discuss a disease that affects a fundamental aspect of life – breathing. Full episode coming soon.

▶︎
If 400m+ people live with COPD, why aren’t we talking about it?

▶︎
Are we turning the tide on superbugs?

▶︎
The Double Click with Shobie Ramakrishnan and Chris Austin: Episode 1

▶︎
Science on the Sofa “Driving Innovation in Oncology Cell Therapies”

▶︎
2025 GSK IMPACT UK Awards

▶︎
Mapping myelofibrosis podcast episode two| Advocacy in focus

▶︎
2026 GSK IMPACT Award Winner - Age UK Norwich

▶︎
Laboratory for Genomics Research

▶︎
Driving Transformation in Cancer Care

▶︎
2026 GSK IMPACT UK Awards

▶︎
The Double Click with Shobie Ramakrishnan, Kaivan Khavandi and Hesham Abdullah: Episode 4

▶︎
Improving representation our clinical trials: HIV

▶︎
The Double Click with Shobie Ramakrishnan and Luis Arosemena: Episode 2

▶︎
Charlie, a myelofibrosis patient, shares her story

▶︎
Using data and tech to improve outcomes for patients with cancer

▶︎
The Double Click with Shobie Ramakrishnan, Patrick Schwab and Francisco Cruz: Episode 5

▶︎
Innovation means more moments like this

▶︎
Simone’s ovarian cancer story

▶︎
